Mengele, the doctor of Auschwitz and ultimate Angel of Death, was an anomaly,
and apparently he lives again in England.
leader in the Nazi biomedical vision, he thrived on experiments with genetic
abnormalities. Even surpassing Hitler at times, Mengele has come to embody the
archetype of Absolute Evil, perhaps because he so egregiously violated his
professional oath to honor and preserve life.
In school, his
specialty had been physical anthropology and genetics, and he was fully
committed to bringing science into the service of the Nazi enterprise. In fact,
he specifically asked to be sent to Auschwitz because of opportunities such a place could provide
for his research.
UK biotechnology industry lobbyists The
BioIndustry Association have “expressed an interest” in making use of patient data held on the NHS
Spine, according to a report published by E-Health Insider today.
Call to use Spine to find drug trial
Association has expressed an interest in tapping into the NHS's Spine database
and using patient information to identify potentially willing drug test
Speaking to the
Scotsman, the association’s chief executive, Aisling Burnand said: “The UK has a real opportunity because the NHS's
patient records make this a unique place in the world to study clinical trends.
We are not there yet, but that is the vision.”
Association spokesperson told E-Health Insider that Burnand was responding to
suggestions made in the Cooksey Review into UK health research funding last December,
and that other research organisations would hold similar interests.
In his foreword
to the review, Sir David Cooksey, said: “The potential offered by the new
‘Connecting for Health’ IT database which will contain the medical records of
the 8m inhabitants of England and should be accessible (with strong patient
confidentiality safeguards) for important research, including clinical trials
and subsequent pharmaco-vigilance studies of newly released drugs.
there are the opportunities offered by the development of biomarkers and the
emerging research into stem cell therapies.
the reorganisation of the NHS R&D function to make it more accessible and
transparent for industry, this opens the door for the UK to excel again in healthcare innovation
and service delivery.
The Review sets
out to describe how this can be delivered. It is a once in a generation
opportunity to do so and for Britain to take a leading position in a major
sector of the knowledge based economy.”
recommended the establishment of a pilot programme, under the joint auspices of
the NHS SDO (Service, Delivery and Organisation) programme and the NHS’
Connecting for Health ‘National Knowledge Service’, to examine the
effectiveness of employing a small number of full-time ‘Knowledge Transfer
Champions’, whose job would be to disseminate the findings of health services
research and facilitate early adoption of those findings into routine practice
in the NHS.
that Connecting for Health was established in 2005 to enhance Knowledge
Reception and Use in the NHS via the National Programme for Information
Programme for Information Technology, operated by NHS Connecting for Health,
may be an important first step in the evolution of decision-based software
systems that healthcare professionals will need in order to manage effectively
the growing scale of our knowledge base and thus improve the care of patients.
programme is not likely to be operational at such a level for some time. Nor
has it been designed specifically for the purpose of knowledge transfer.
“In any event,
the uptake of new knowledge, particularly complex information, often depends
the direct communication of new potential users with those familiar with that
new technology, so that solutions involving information technology are unlikely
to be entirely sufficient.
marketing or information campaigns are unlikely to adequately support the
spread of these types of knowledge within the health services.”
Association spokesperson told EHI that CfH have been working with the UK
Clinical Research Collaboration to ensure that the Spine does have a strong
research component, but discussions relating to usage of any data stored will
need to wait until progress has been made on delivering the system.
Health’s director of clinical knowledge, process and safety, Sir Muir Gray
said: “There are still major problems in implementing best current evidence
and I am in discussion with the producers of research evidence to discuss ways
in which their outputs could be much more easily and quickly put into practice.”
Knowledge Service http://www.nks.nhs.uk/